Colgate-Palmolive Förvaltning
Förvaltning kriterier kontrolleras 4/4
Colgate-Palmolive VD är Noel Wallace, utsedd i Jul 2018, har en mandatperiod på 7.83 år. totala årliga ersättningen är $ 16.48M, bestående av 9.1% lön 90.9% bonusar, inklusive företagsaktier och optioner. äger direkt 0.052% av företagets aktier, värda $ 36.41M. Den genomsnittliga mandatperioden för ledningsgruppen och styrelsen är 3.5 år respektive 7.1 år.
Viktig information
Noel Wallace
Verkställande direktör
US$16.5m
Total ersättning
| VD-lön i procent | 9.10% |
| Anställning som VD | 7.8yrs |
| Ägande av VD | 0.05% |
| Ledningens genomsnittliga anställningstid | 3.5yrs |
| Styrelsens genomsnittliga mandatperiod | 7.1yrs |
Senaste uppdateringar av ledningen
Recent updates
Colgate-Palmolive: A Resilient Dividend King Navigating A Tougher Environment
May 02
CL: 2030 Plan Execution And Margins Will Shape 2026 Setup
Analysts have trimmed the Colgate-Palmolive fair value estimate by about $0.58 to $96.68, reflecting slightly softer revenue growth assumptions, a modestly lower future P/E, and mixed recent research that includes both reduced price targets and an upgrade tied to confidence in the 2030 plan and ongoing margin resilience. Analyst Commentary Recent Street research on Colgate-Palmolive shows a mix of optimism around the long-term plan and caution around nearer term cost and valuation risks.CL: 2030 Plan And Emerging Markets Execution Will Shape 2026 Setup
Colgate-Palmolive's fair value estimate edges up to $97.26 from $97.21 as analysts lift price targets toward the $100 to $105 range, citing stronger confidence in the 2030 plan, product innovation, and emerging markets execution. Analyst Commentary Recent Street research on Colgate-Palmolive clusters around higher price targets and upgraded ratings, with the fair value conversation increasingly framed around the 2030 plan, execution in emerging markets, and portfolio moves such as the exit from private label pet food.CL: 2030 Plan And Emerging Markets Support Measured 2026 Execution Setup
Analysts have nudged their price expectations for Colgate-Palmolive higher, with the updated fair value estimate moving from about $96.68 to roughly $97.21. They cite growing confidence in the company’s 2030 plan, product innovation efforts and emerging markets exposure, as reflected in a series of recent price target increases across major firms.CL: 2030 Plan And Emerging Markets Will Drive Balanced 2026 Setup
Analysts have raised their implied price target for Colgate-Palmolive by about $8 to reflect higher conviction in the company’s 2030 plan, product innovation pipeline and emerging market exposure, as well as refreshed views on sector valuations. Analyst Commentary Recent research has centered on how Colgate-Palmolive’s 2030 plan, product pipeline and emerging market footprint feed into both growth potential and current valuation.There May Be Some Bright Spots In Colgate-Palmolive's (NYSE:CL) Earnings
Feb 06
CL: Emerging Markets And 2026 Setup Will Shape Balanced Risk Reward
Analysts have nudged their price targets for Colgate-Palmolive higher, reflected in a modest fair value move from about $87.47 to $88.89. They are factoring in slightly stronger revenue growth assumptions, a marginally higher future P/E and recent rating and target changes across firms such as Barclays, JPMorgan, UBS, Wells Fargo, Piper Sandler and TD Cowen.CL: Emerging Markets And 2026 Setup Support Balanced Outlook After Recent Softness
Our updated analyst price target for Colgate-Palmolive edges up to about US$87.47 from roughly US$87.21, as analysts balance slightly softer modeled revenue growth with modestly higher profit margin and future P/E assumptions. This view is supported by recent research that pairs cautious consumer staples outlooks with a more positive stance on the company’s emerging markets exposure and potential 2026 acceleration.CL: Emerging Market Strength Will Support Gradual Recovery As Q3 Softness Fades
Analysts have trimmed their price target on Colgate-Palmolive to $87 from the low-to-mid $90s, reflecting near term softness in Q3 results and muted personal care growth, even as they expect organic sales momentum to gradually improve. Analyst Commentary Analysts remain divided on Colgate-Palmolive, with recent target cuts reflecting near term execution risk, while longer term growth and margin recovery expectations stay largely intact.CL: Gradual Recovery Expected As Temporary Headwinds Ease In Personal Care Markets
Narrative Update on Colgate-Palmolive Colgate-Palmolive's analyst price target has been modestly reduced by $0.05 to $87.21. Analysts cite near-term growth challenges and muted sector outlooks following a soft Q3, but expect gradual improvement as temporary pressures ease.CL: Organic Sales Momentum Will Rebound As Near-Term Headwinds Ease
Colgate-Palmolive's analyst consensus price target was revised downward from approximately $88.84 to $87.26. Analysts cite a soft third quarter, moderated growth expectations, and ongoing category headwinds as key factors behind the adjustment.CL: Future Cost Optimization Will Drive Competitive Advantage Amid Category Headwinds
Colgate-Palmolive’s fair value estimate has been reduced from $90.74 to $88.84 per share. Analysts cite persistent category headwinds and a moderated sales outlook as factors behind lower price targets across the sector.Emerging Markets And Digital Transformation Will Unlock Global Value
Colgate-Palmolive's analyst fair value price target has decreased from $93.11 to $90.74. Analysts cite lowered sales guidance, persistent category headwinds, and muted growth outlooks as key factors behind their revised estimates.Emerging Markets And Digital Transformation Will Unlock Global Value
Colgate-Palmolive's analyst price target has been revised downward by approximately $2 to $93. Analysts cite ongoing category headwinds and decelerating growth in the personal care sector as reasons for this adjustment.There's Reason For Concern Over Colgate-Palmolive Company's (NYSE:CL) Price
Sep 30Colgate-Palmolive Company (NYSE:CL) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Aug 04
Colgate-Palmolive (NYSE:CL) Has A Pretty Healthy Balance Sheet
Jun 27Do Colgate-Palmolive's (NYSE:CL) Earnings Warrant Your Attention?
Jun 12The Trend Of High Returns At Colgate-Palmolive (NYSE:CL) Has Us Very Interested
May 15A Historic Brand, A Fresh Approach: Inside Colgate-Palmolive's Machine
Apr 22Colgate-Palmolive: A Defensive Stock With Growth Potential
Mar 20Is Colgate-Palmolive Quietly Building The Next Pet Food Empire?
Mar 14Colgate-Palmolive: Don't Get Your Hopes Up (Yet)
Feb 25Colgate-Palmolive Stock: Post-Earnings Drop Isn't A Buy-The-Dip Moment
Jan 31Colgate-Palmolive: Digital Advertising Is The Base From Which To Start Again
Dec 17Colgate-Palmolive: Approaching Buy Territory With Some Important Catalysts
Dec 11Colgate-Palmolive Q3: Great Company, But Not Enough To Warrant A Position Now
Oct 25Colgate-Palmolive: Very Close To A Buy Following Recent Pullback
Oct 17Colgate-Palmolive: Share Price Returns Should Moderate (Rating Downgrade)
Sep 30Colgate-Palmolive: Stability Pillar Reached Its Fair Value
Aug 19Analys av ersättningar till VD
| Datum | Total ersättning | Lön | Företagets resultat |
|---|---|---|---|
| Dec 31 2025 | US$16m | US$2m | US$2b |
| Sep 30 2025 | n/a | n/a | US$3b |
| Jun 30 2025 | n/a | n/a | US$3b |
| Mar 31 2025 | n/a | n/a | US$3b |
| Dec 31 2024 | US$18m | US$2m | US$3b |
| Sep 30 2024 | n/a | n/a | US$3b |
| Jun 30 2024 | n/a | n/a | US$3b |
| Mar 31 2024 | n/a | n/a | US$3b |
| Dec 31 2023 | US$17m | US$1m | US$2b |
| Sep 30 2023 | n/a | n/a | US$2b |
| Jun 30 2023 | n/a | n/a | US$1b |
| Mar 31 2023 | n/a | n/a | US$2b |
| Dec 31 2022 | US$14m | US$1m | US$2b |
| Sep 30 2022 | n/a | n/a | US$2b |
| Jun 30 2022 | n/a | n/a | US$2b |
| Mar 31 2022 | n/a | n/a | US$2b |
| Dec 31 2021 | US$15m | US$1m | US$2b |
| Sep 30 2021 | n/a | n/a | US$3b |
| Jun 30 2021 | n/a | n/a | US$3b |
| Mar 31 2021 | n/a | n/a | US$3b |
| Dec 31 2020 | US$14m | US$1m | US$3b |
| Sep 30 2020 | n/a | n/a | US$3b |
| Jun 30 2020 | n/a | n/a | US$3b |
| Mar 31 2020 | n/a | n/a | US$3b |
| Dec 31 2019 | US$11m | US$1m | US$2b |
Ersättning vs marknad: Noel s total kompensation ($USD 16.48M ) är ungefär genomsnittet för företag av liknande storlek på US marknaden ($USD 14.58M ).
Ersättning vs inkomst: Ersättningen från Noel har varit i linje med företagets resultat under det senaste året.
VD OCH KONCERNCHEF
Noel Wallace (61 yo)
7.8yrs
Anställning
US$16,478,196
Kompensation
Mr. Noel R. Wallace serves as Chief Executive Officer and Director of Colgate-Palmolive Company since April 2, 2019 and has been its President since July 11, 2018. Mr. Wallace serves as Chairman of Colgate...
Ledningsgrupp
| Namn | Position | Anställning | Kompensation | Ägarskap |
|---|---|---|---|---|
| Chairman | 7.8yrs | US$16.48m | 0.052% $ 36.4m | |
| Chief Financial Officer | 5.5yrs | US$5.66m | 0.0075% $ 5.2m | |
| Chief Legal Officer & Secretary | 11.5yrs | US$3.77m | 0.010% $ 7.2m | |
| COO of Europe | 6.8yrs | US$4.08m | 0.0099% $ 6.9m | |
| Chief Operating Officer of Americas | less than a year | US$11.92m | inga uppgifter | |
| Chief Technology Officer | 3.7yrs | inga uppgifter | inga uppgifter | |
| Chief Information Officer | 3.3yrs | inga uppgifter | inga uppgifter | |
| Executive Vice President of Investor Relations | less than a year | inga uppgifter | inga uppgifter | |
| Executive Vice President of Internal Audit & Compliance | 1.3yrs | inga uppgifter | inga uppgifter | |
| Chief Communications Officer | 1.2yrs | inga uppgifter | inga uppgifter | |
| Executive VP of Marketing - Latin America | 1.3yrs | inga uppgifter | inga uppgifter | |
| Chief Human Resources Officer | 6.3yrs | inga uppgifter | 0.0038% $ 2.7m |
3.5yrs
Genomsnittlig anställningstid
59yo
Genomsnittlig ålder
Erfaren ledning: CL s ledningsgrupp anses vara erfaren ( 3.5 års genomsnittlig anställningstid).
Styrelseledamöter
| Namn | Position | Anställning | Kompensation | Ägarskap |
|---|---|---|---|---|
| Chairman | 7.1yrs | US$16.48m | 0.052% $ 36.4m | |
| Independent Director | 20.6yrs | US$315.68k | 0.0045% $ 3.2m | |
| Independent Director | 10.2yrs | US$313.16k | 0.0020% $ 1.4m | |
| Independent Director | 7.2yrs | US$300.31k | 0.0016% $ 1.1m | |
| Lead Independent Director | 10.7yrs | US$336.18k | 0.00011% $ 76.8k | |
| Independent Director | 6.2yrs | US$315.41k | 0.00035% $ 244.4k | |
| Independent Director | 3.3yrs | US$300.31k | 0.00074% $ 516.7k | |
| Independent Director | 11.2yrs | US$315.68k | 0.00074% $ 516.7k | |
| Independent Director | 5.2yrs | US$308.41k | 0.00040% $ 279.3k | |
| Independent Director | less than a year | inga uppgifter | inga uppgifter | |
| Independent Director | 2.2yrs | US$308.31k | 0.00046% $ 321.2k |
7.1yrs
Genomsnittlig anställningstid
63yo
Genomsnittlig ålder
Erfaren styrelse: CL s styrelse anses vara erfaren ( 7.1 års genomsnittlig mandatperiod).
Företagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/05/04 05:02 |
| Aktiekurs vid dagens slut | 2026/05/04 00:00 |
| Intäkter | 2026/03/31 |
| Årlig intjäning | 2025/12/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
Colgate-Palmolive Company bevakas av 43 analytiker. 17 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| Christopher Graja | Argus Research Company |
| Lauren Lieberman | Barclays |
| Lauren Lieberman | Barclays |